Medical devices whose components include materials of biological origin require special risk management. In the first part of our series of articles on “Zoonoses”, we tell you how to meet the requirements of the MDR.
In China, Post Market Surveillance (PMS) is an important component of the regulation for medical devices, ensuring the safety and effectiveness of these products.
The AET is an essential component for the biological safety assessment of the chemical characterisation of leachable substances in medical devices. Read details about the AET here.
Assembled medical devices are referred to as systems and procedure packs under the MDR. Separate regulatory requirements of Regulation EU 2017/745 apply to these.